EP 1401440 A4 20060705 - METHODS OF USE OF FLUOROQUINOLONE COMPOUNDS AGAINST BACTERIA

Title (en)

METHODS OF USE OF FLUOROQUINOLONE COMPOUNDS AGAINST BACTERIA

Title (de)

VERFAHREN ZUR VERWENDUNG VON FLUORCHINOLONE VERBINDUNGEN GEGEN BAKTERIEN

Title (fr)

PROCEDES D'UTILISATION DES COMPOSES DES FLUOROQUINOLONES CONTRE LES BACTERIES

Publication

EP 1401440 A4 20060705 (EN)

Application

EP 00993844 A 20000831

Priority

US 0023883 W 20000831
US 15183699 P 19990901
US 15196099 P 19990901
US 15191799 P 19990901
US 15183599 P 19990901
US 15183799 P 19990901
US 15183499 P 19990901
US 15411599 P 19990914
US 15388499 P 19990914
US 15534999 P 19990922
US 15538399 P 19990922
US 15538099 P 19990922
US 15534899 P 19990922
US 15539399 P 19990922
US 15515099 P 19990922
US 15537999 P 19990922
US 15539599 P 19990922
US 15535899 P 19990922
US 15534699 P 19990922
US 15514999 P 19990922
US 15534499 P 19990922
US 15539199 P 19990922
US 15538199 P 19990922
US 15535999 P 19990922
US 15533899 P 19990922
US 15538499 P 19990922
US 15534099 P 19990922
US 15538299 P 19990922
US 15539499 P 19990922
US 15539299 P 19990922
US 15534799 P 19990922
US 15514899 P 19990922
US 15536099 P 19990922
US 15586999 P 19990924
US 15586899 P 19990924
US 15595799 P 19990924

Abstract (en)

[origin: WO0115695A1] This invention relates, in part, to newly identifid methods of using quinolone antibiotics, particulrly a gemifloxacin compound against certain bactera, especially pathogenic bacteria.

IPC 8 full level

A61K 31/44 (2006.01); A61K 31/444 (2006.01); A61P 31/04 (2006.01); C07D 471/04 (2006.01)

CPC (source: EP)

A61K 31/44 (2013.01); A61P 31/04 (2017.12)

Citation (search report)

[DXY] OH J-I ET AL: "IN VITRO AND IN VIVO EVALUATIONS OF LB20304, A NEW FLUORONAPHTHYRIDONE", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, vol. 40, no. 6, June 1996 (1996-06-01), pages 1564 - 1568, XP000911979, ISSN: 0066-4804
[XY] BERRY V ET AL: "COMPARATIVE EFFICACY OF GEMIFLOXACIN AGAINST EXPERIMENTAL RTI IN RATS CAUSED BY S. PNEUMONIAE", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, SAUNDERS CO. LTD., LONDON, GB, vol. 44, no. SUPPL A, 4 July 1999 (1999-07-04), pages 148,ANP492, XP008009869, ISSN: 0305-7453
[XDY] CORMICAN M G ET AL: "ANTIMICROBIAL ACTIVITY AND SPECTRUM OF LB20304, A NOVEL FLUORONAPHTHYRIDONE", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, vol. 41, no. 1, January 1997 (1997-01-01), pages 204 - 211, XP000911943, ISSN: 0066-4804
[XY] JOHNSON D M ET AL: "ANTI-STREPTOCOCCAL ACTIVITY OF SB-265805 (LB20304, A NOVEL FLUORONAPHTHYRIDONE, COMPARED WITH FIVE OTHER COMPOUNDS, INCLUDING QUALITY CONTROL GUIDELINES", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASES, ELSEVIER SCIENCE PUBLISHING CO., AMSTERDAM, NL, vol. 33, no. 2, February 1999 (1999-02-01), pages 87 - 91, XP000911956, ISSN: 0732-8893
[Y] MA Z: "GEMIFLOXACIN LG CHEMICAL LTD", CURRENT OPINION IN ANTI-INFECTIVE INVESTIGATIONAL DRUGS, PHARMA PRESS,, GB, vol. 1, no. 4, 1999, pages 493 - 500, XP008009846, ISSN: 1464-8458
[PXY] MACKENZIE H ET AL: "Postantibiotic effect (PAE) of gemifloxacin (SB-265805) in S. pneumoniae with diminished susceptibility to ciprofloxacin", ABSTRACTS OF THE INTERSCIENCE CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 39, 1999, & 39TH INTERSCIENCE CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; SAN FRANCISCO, CALIFORNIA, USA; SEPTEMBER 26-29, 1999, pages 268, XP001246835
See references of WO 0115695A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 0115695 A1 20010308; AU 6947900 A 20010326; EP 1401440 A1 20040331; EP 1401440 A4 20060705; JP 2004507440 A 20040311

DOCDB simple family (application)

US 0023883 W 20000831; AU 6947900 A 20000831; EP 00993844 A 20000831; JP 2001519909 A 20000831